These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 34068715)

  • 1. Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety.
    Vlatkovic I
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34068715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unlocking the Therapeutic Applicability of LNP-mRNA: Chemistry, Formulation, and Clinical Strategies.
    Huang X; Ma Y; Ma G; Xia Y
    Research (Wash D C); 2024; 7():0370. PubMed ID: 38894715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells.
    Bevers S; Kooijmans SAA; Van de Velde E; Evers MJW; Seghers S; Gitz-Francois JJJM; van Kronenburg NCH; Fens MHAM; Mastrobattista E; Hassler L; Sork H; Lehto T; Ahmed KE; El Andaloussi S; Fiedler K; Breckpot K; Maes M; Van Hoorick D; Bastogne T; Schiffelers RM; De Koker S
    Mol Ther; 2022 Sep; 30(9):3078-3094. PubMed ID: 35821637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.
    Saunders KO; Pardi N; Parks R; Santra S; Mu Z; Sutherland L; Scearce R; Barr M; Eaton A; Hernandez G; Goodman D; Hogan MJ; Tombacz I; Gordon DN; Rountree RW; Wang Y; Lewis MG; Pierson TC; Barbosa C; Tam Y; Matyas GR; Rao M; Beck Z; Shen X; Ferrari G; Tomaras GD; Montefiori DC; Weissman D; Haynes BF
    NPJ Vaccines; 2021 Apr; 6(1):50. PubMed ID: 33837212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design Strategies for and Stability of mRNA-Lipid Nanoparticle COVID-19 Vaccines.
    Liu T; Tian Y; Zheng A; Cui C
    Polymers (Basel); 2022 Oct; 14(19):. PubMed ID: 36236141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque.
    Naderi Sohi A; Kiani J; Arefian E; Khosrojerdi A; Fekrirad Z; Ghaemi S; Zim MK; Jalili A; Bostanshirin N; Soleimani M
    Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA Vaccines Encoding the HA Protein of Influenza A H1N1 Virus Delivered by Cationic Lipid Nanoparticles Induce Protective Immune Responses in Mice.
    Zhuang X; Qi Y; Wang M; Yu N; Nan F; Zhang H; Tian M; Li C; Lu H; Jin N
    Vaccines (Basel); 2020 Mar; 8(1):. PubMed ID: 32164372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates.
    Monslow MA; Elbashir S; Sullivan NL; Thiriot DS; Ahl P; Smith J; Miller E; Cook J; Cosmi S; Thoryk E; Citron M; Thambi N; Shaw C; Hazuda D; Vora KA
    Vaccine; 2020 Aug; 38(36):5793-5802. PubMed ID: 32703745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Delivery of RNA Encoding Anti-PD-1 Human Monoclonal Antibody for Treating Intestinal Cancer.
    Wu L; Wang W; Tian J; Qi C; Cai Z; Yan W; Xuan S; Shang A
    J Cancer; 2022; 13(2):579-588. PubMed ID: 35069904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA-based therapies: Preclinical and clinical applications.
    Qureischi M; Mohr J; Arellano-Viera E; Knudsen SE; Vohidov F; Garitano-Trojaola A
    Int Rev Cell Mol Biol; 2022; 372():1-54. PubMed ID: 36064262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and patent prospective of lipid nanoparticle for mRNA delivery.
    Zhang HL
    Expert Opin Ther Pat; 2023 Feb; 33(2):125-131. PubMed ID: 36958374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy.
    Zong Y; Lin Y; Wei T; Cheng Q
    Adv Mater; 2023 Dec; 35(51):e2303261. PubMed ID: 37196221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity.
    Wu L; Li X; Qian X; Wang S; Liu J; Yan J
    Vaccines (Basel); 2024 Feb; 12(2):. PubMed ID: 38400169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model.
    Daly O; Mahiny AJ; Majeski S; McClintock K; Reichert J; Boros G; Szabó GT; Reinholz J; Schreiner P; Reid S; Lam K; Lepper M; Adler M; Meffen T; Heyes J; Karikó K; Lutwyche P; Vlatkovic I
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics.
    Semple SC; Leone R; Barbosa CJ; Tam YK; Lin PJC
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the impact of
    Lenk R; Kleindienst W; Szabó GT; Baiersdörfer M; Boros G; Keller JM; Mahiny AJ; Vlatkovic I
    Front Mol Biosci; 2024; 11():1426129. PubMed ID: 39050733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
    Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
    Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA-LNP-Based Vaccines.
    Patel N; Davis Z; Hofmann C; Vlasak J; Loughney JW; DePhillips P; Mukherjee M
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery.
    Żak MM; Zangi L
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo.
    Rybakova Y; Kowalski PS; Huang Y; Gonzalez JT; Heartlein MW; DeRosa F; Delcassian D; Anderson DG
    Mol Ther; 2019 Aug; 27(8):1415-1423. PubMed ID: 31160223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.